> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Launches CURE ID Internet Repository
- URL: https://www.fdaweb.com/fda-launches-cure-id-internet-repository/
- Published: 2019-12-05T12:00:00.000Z
- Updated: 2026-09-14T15:55:30.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5145665

FDA has launched CURE ID, an Internet-based repository that will allow the clinical community to report their experiences treating difficult-to-treat infectious diseases with novel uses of existing FDA-approved drugs through a Web site, smart phone, or other mobile device. An agency [statement](https://www.prnewswire.com/news-releases/fda-launches-app-for-health-care-professionals-to-report-novel-uses-of-existing-medicines-for-patients-with-difficult-to-treat-infectious-diseases-300970120.html?ref=fdaweb.com) says the platform “enables the crowdsourcing of medical information from healthcare providers to guide potentially life-saving interventions and facilitate the development of new drugs for neglected diseases.”

The repository is a collaboration between FDA and the National Center for Advancing Translational Sciences, part of the National Institutes of Health.

The repository captures clinical outcomes when drugs are used for new indications, in new populations, in new doses, or in new combinations, FDA says. “The systematic collection of real-world experience in the app will help identify drug candidates for additional study, encourage further drug development, and may serve as a resource for practitioners making individual patient treatment decisions in the absence of established safe and effective options,” FDA says. “Repurposing approved drugs for new clinical indications can potentially offer an efficient drug-development pathway for treatments of diseases and conditions that have few or no therapeutic options.”